Clinical Trial Update: Dose, Effects and Characteristics of Pilocarpine [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the dose, effects, and characteristics of pilocarpine in open-angle glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Pilocarpine (pilocarpine)

Snippet

Sponsor: Wills Eye | Conditions: Open-angle Glaucoma | Phase 4 | Status: COMPLETED